Acadia Pharmaceuticals
ACAD
ACAD
236 hedge funds and large institutions have $2.4B invested in Acadia Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 77 increasing their positions, 81 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
19% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 37
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
33% less capital invested
Capital invested by funds: $3.61B → $2.4B (-$1.2B)
Holders
236
Holding in Top 10
2
Calls
$22M
Puts
$8.23M
Top Buyers
| 1 | +$29.2M | |
| 2 | +$13.4M | |
| 3 | +$11.1M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$10.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.1M |
Top Sellers
| 1 | -$68.5M | |
| 2 | -$24.4M | |
| 3 | -$17.4M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$12.7M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$10.9M |